Celgene email design inspirations, newsletters, and email subjects

Filter
Date
More

Domains

Add a Domain or Brand

Mails

Total result: 99
Page
of 1
The Biotech Rebound Is Just Beginning
stansberryresearch.com
The Biotech Rebound Is Just Beginning
Sent On

20/03/2024

WOW! Record Setting Volume (TCBP) #1 Alert Service In the Country
10xprotrader.com
WOW! Record Setting Volume (TCBP) #1 Alert Service In the Country
Sent On

23/10/2023

BOMBSHELL News Hits Wire on [Nasdaq: TCBP] Shares Go Vertical - Volume Spike
10xprotrader.com
BOMBSHELL News Hits Wire on [Nasdaq: TCBP] Shares Go Vertical - Volume Spike
Sent On

23/10/2023

[Premium Alert] The Market Opens in 30 mins $.50 Biotech Can Sky-Rocket (Open Read Why)
10xprotrader.com
[Premium Alert] The Market Opens in 30 mins $.50 Biotech Can Sky-Rocket (Open Read Why)
Sent On

23/10/2023

[Premium Alert] 3 Reasons Why This $.50 Biotech Can Sky-Rocket (Open Read Why)
10xprotrader.com
[Premium Alert] 3 Reasons Why This $.50 Biotech Can Sky-Rocket (Open Read Why)
Sent On

23/10/2023

Monday's Premium Alert! Analyst Predict 1,607% Upside - See $.50 Biotech Gets $7 Price Target
10xprotrader.com
Monday's Premium Alert! Analyst Predict 1,607% Upside - See $.50 Biotech Gets $7 Price Target
Sent On

22/10/2023

LOOK@ [New Premium Alert] For Monday - Must See $.50 Biotech Gets $7 Price Target
10xprotrader.com
LOOK@ [New Premium Alert] For Monday - Must See $.50 Biotech Gets $7 Price Target
Sent On

22/10/2023

$.50 Nasdaq Biotech [Premium Alert] Receives $7 Target Price by Analyst - 1,607% Upside
10xprotrader.com
$.50 Nasdaq Biotech [Premium Alert] Receives $7 Target Price by Analyst - 1,607% Upside
Sent On

21/10/2023

New [Premium Alert] $.50 Nasdaq Biotech Receives $7 Target Price by Analyst - 1,607% Upside
10xprotrader.com
New [Premium Alert] $.50 Nasdaq Biotech Receives $7 Target Price by Analyst - 1,607% Upside
Sent On

21/10/2023

[Premium Alert] This $.50 Nasdaq Biotech Receives $7 Target Price by Analyst - 1,607% Upside
10xprotrader.com
[Premium Alert] This $.50 Nasdaq Biotech Receives $7 Target Price by Analyst - 1,607% Upside
Sent On

20/10/2023

The best stock analyst on Earth?
empirefinancialresearch.com
The best stock analyst on Earth?
Sent On

09/10/2023

Holy Smokes...My Alert (TCBP) Sky-Rocketed from $6.64 to a jolting high of $8.37
10xprotrader.com
Holy Smokes...My Alert (TCBP) Sky-Rocketed from $6.64 to a jolting high of $8.37
Sent On

18/01/2023

WOW! Do You See (TCBP)? The Stock is Absolutely Surging Up In Price in Pre-Market
10xprotrader.com
WOW! Do You See (TCBP)? The Stock is Absolutely Surging Up In Price in Pre-Market
Sent On

18/01/2023

[PREMIUM ALERT] NASDAQ Biotech Stock (TCBP) Setting Up for Early BREAKOUT!
10xprotrader.com
[PREMIUM ALERT] NASDAQ Biotech Stock (TCBP) Setting Up for Early BREAKOUT!
Sent On

18/01/2023

[Premium Alert] My \
10xprotrader.com
[Premium Alert] My \"Two-Time\" Winning NASDAQ Biotech Stock (Details Inside)
Sent On

17/01/2023

[New Premium Alert] \
10xprotrader.com
[New Premium Alert] \"Two-Time\" Big Winning NASDAQ Biotech Stock (Details Inside)
Sent On

17/01/2023

Today's Premium Alert (TCBP) Soars To $7.95 (Do NOT Miss Out) Open Now
10xprotrader.com
Today's Premium Alert (TCBP) Soars To $7.95 (Do NOT Miss Out) Open Now
Sent On

22/11/2022

[BLOCKBUSTER NEWS!] TC BioPharm Begins Phase 2B trial, dubbed ACHIEVE!
10xprotrader.com
[BLOCKBUSTER NEWS!] TC BioPharm Begins Phase 2B trial, dubbed ACHIEVE!
Sent On

22/11/2022

[Explosive Catalyst!] Nasdaq Biotech Breakout Stock with Tiny Float & Tremendous Upside Potential
10xprotrader.com
[Explosive Catalyst!] Nasdaq Biotech Breakout Stock with Tiny Float & Tremendous Upside Potential
Sent On

22/11/2022

[BREAKOUT ALERT!] Imminent FDA Approval Could Send This Tiny Nasdaq Biotech Soaring (Symbol Inside)
10xprotrader.com
[BREAKOUT ALERT!] Imminent FDA Approval Could Send This Tiny Nasdaq Biotech Soaring (Symbol Inside)
Sent On

22/11/2022

[BIOTECH ALERT!] Imminent FDA Approval Could Send This Tiny Biotech Soaring (Symbol Inside)
10xprotrader.com
[BIOTECH ALERT!] Imminent FDA Approval Could Send This Tiny Biotech Soaring (Symbol Inside)
Sent On

21/11/2022

Unusual stock is up 66.3% since May 11
libertythroughwealth.com
Unusual stock is up 66.3% since May 11
Sent On

28/07/2022

What Is Biotechnology?
topstocktips.com
What Is Biotechnology?
Sent On

25/03/2022

What Is Biotechnology?
topstocktips.com
What Is Biotechnology?
Sent On

22/03/2022

Trading Opportunities: A Small Biotech Stock That Has All The Right Ingredients for a Big 2021 Breakout
investorplace.com
Trading Opportunities: A Small Biotech Stock That Has All The Right Ingredients for a Big 2021 Breakout
Sent On

30/04/2021

The Legal Way to Profit From \
palmbeachgroup.com
The Legal Way to Profit From \"Insider\" Trading
Sent On

11/02/2021

NASDAQ Stock BioSig Technologies, Inc. (BSGM) Releases Breaking News Just Now...
fierceanalyst.net
NASDAQ Stock BioSig Technologies, Inc. (BSGM) Releases Breaking News Just Now...
Sent On

17/06/2020

NASDAQ Stock BioSig Technologies, Inc. (BSGM) Analyst Price Targets As High Of $17/share
fierceanalyst.net
NASDAQ Stock BioSig Technologies, Inc. (BSGM) Analyst Price Targets As High Of $17/share
Sent On

17/06/2020

Buy This $140 Billion Pharma Powerhouse Now
banyanhill.com
Buy This $140 Billion Pharma Powerhouse Now
Sent On

23/05/2020

New (NASDAQ) Stock Profile: BioSig Technologies, Inc. (BSGM) Breaking News Just Hit -Multiple Wall Street Analysts Interested
fierceanalyst.net
New (NASDAQ) Stock Profile: BioSig Technologies, Inc. (BSGM) Breaking News Just Hit -Multiple Wall Street Analysts Interested
Sent On

19/02/2020

The Biotech Revolution: Profiting From the Future of Science
zacks.com
The Biotech Revolution: Profiting From the Future of Science
Sent On

08/02/2020

2⃣ Two Off-The-Radar Stocks With High Dividend Yields and Reasonable Growth
tradingtips.com
2⃣ Two Off-The-Radar Stocks With High Dividend Yields and Reasonable Growth
Sent On

19/11/2019

Monroe Capital: This 13% Yielder Is Clearly Oversold
seekingalpha.com
Monroe Capital: This 13% Yielder Is Clearly Oversold
Sent On

25/10/2019

Energy Transfer Partners: Dispelling The Myth Surrounding Its Record Debt
seekingalpha.com
Energy Transfer Partners: Dispelling The Myth Surrounding Its Record Debt
Sent On

28/08/2019

Daily business briefing
theweek.com
Daily business briefing
Sent On

27/08/2019

🇺🇸 Markets Rally as U.S./China Look to Restart Trade Talks
tradingtips.com
🇺🇸 Markets Rally as U.S./China Look to Restart Trade Talks
Sent On

27/08/2019

FW: ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
jamesaltucher.com
FW: ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
Sent On

08/08/2019

ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
jamesaltucher.com
ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
Sent On

16/07/2019

ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
gilderpress.com
ALZHEIMER’S BREAKTHROUGH: huge opportunity (and $$$) ahead if FDA grants urgent approval
Sent On

13/07/2019

👉 Markets Calm Despite Iran Sanctions, G20 Meeting This Week
tradingtips.com
👉 Markets Calm Despite Iran Sanctions, G20 Meeting This Week
Sent On

25/06/2019

Boeing Shocks With 737 MAX Announcement
seekingalpha.com
Boeing Shocks With 737 MAX Announcement
Sent On

21/06/2019

Today’s News: Stocks Are Up Today. Here's Why
theconservativeinvestordaily-mail.com
Today’s News: Stocks Are Up Today. Here's Why
Sent On

16/04/2019

Carlson Capital Arbitrage Profits From Celgene/Bristol-Myers Mega Deal
valuewalk.com
Carlson Capital Arbitrage Profits From Celgene/Bristol-Myers Mega Deal
Sent On

13/04/2019

Breaking Down Aurora's Investor Presentation And Why There Is Massive Room To Grow
seekingalpha.com
Breaking Down Aurora's Investor Presentation And Why There Is Massive Room To Grow
Sent On

01/04/2019

Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
foolmart.com
Is Celgene and Bristol-Myers a Match Made in Heaven or Doomed to Fail?
Sent On

22/03/2019

Mixed Economic, Geopolitical News May Lead To Choppy Trading
advfn.co.uk
Mixed Economic, Geopolitical News May Lead To Choppy Trading
Sent On

28/02/2019

Karl Lagerfeld, Chanel designer, is dead at 85
vox.com
Karl Lagerfeld, Chanel designer, is dead at 85
Sent On

19/02/2019

Vibrators are officially Instagram-friendly
vox.com
Vibrators are officially Instagram-friendly
Sent On

15/02/2019

2 Dividend Blue-Chips Set To Soar And 1 You Should Ignore
seekingalpha.com
2 Dividend Blue-Chips Set To Soar And 1 You Should Ignore
Sent On

13/02/2019

Your $200 bonus expires in 55 minutes
investorplace.com
Your $200 bonus expires in 55 minutes
Sent On

25/01/2019

Big Pharma Is Buying These Companies—So Should You
palmbeachgroup.com
Big Pharma Is Buying These Companies—So Should You
Sent On

15/01/2019

Enterprise Products Partners: A Compelling Case For Upside
seekingalpha.com
Enterprise Products Partners: A Compelling Case For Upside
Sent On

07/01/2019

What Should Celgene Shareholders Do In Light Of The Bristol-Myers Squibb Deal?
seekingalpha.com
What Should Celgene Shareholders Do In Light Of The Bristol-Myers Squibb Deal?
Sent On

05/01/2019

Stock Strategist: Bristol Broadens Pipeline With Celgene Buy
morningstar.com
Stock Strategist: Bristol Broadens Pipeline With Celgene Buy
Sent On

04/01/2019

One Stock to Sell in the Rebound Rally
tradespoon.com
One Stock to Sell in the Rebound Rally
Sent On

04/01/2019

Apple comes clean, leaves investors stuck in the mud
bloombergview.com
Apple comes clean, leaves investors stuck in the mud
Sent On

03/01/2019

Lower Apple Guidance Likely To Weigh On Wall Street
advfn.co.uk
Lower Apple Guidance Likely To Weigh On Wall Street
Sent On

03/01/2019

Hot stock: Why did $CELG Celgene Corporation jump 30.63% to 87?
whotrades.eu
Hot stock: Why did $CELG Celgene Corporation jump 30.63% to 87?
Sent On

03/01/2019

Can This Tech Stock Rebound in 2019?
investingdaily.com
Can This Tech Stock Rebound in 2019?
Sent On

03/12/2018

Celgene CEO: Treating cancer is becoming 'ironically easy'
geekwire.com
Celgene CEO: Treating cancer is becoming 'ironically easy'
Sent On

26/10/2018

On Politics With Lisa Lerer: They’re Running? Not Yet. (But Yes.)
nytimes.com
On Politics With Lisa Lerer: They’re Running? Not Yet. (But Yes.)
Sent On

10/10/2018

Your Rent Laws Are at Stake Here
wnyc.org
Your Rent Laws Are at Stake Here
Sent On

24/09/2018

Canopy Growth Is A High-Conviction Short: Shareholders Were Diluted 50% And Didn't Notice
seekingalpha.com
Canopy Growth Is A High-Conviction Short: Shareholders Were Diluted 50% And Didn't Notice
Sent On

06/09/2018

General Electric: Strong Buy
seekingalpha.com
General Electric: Strong Buy
Sent On

02/06/2018

Is It Too Late To Buy Microsoft?
seekingalpha.com
Is It Too Late To Buy Microsoft?
Sent On

29/05/2018

Surgery Sticker Shock; Games Drugmakers Play; Psychedelic Science
npr.org
Surgery Sticker Shock; Games Drugmakers Play; Psychedelic Science
Sent On

20/05/2018

5 Top Stocks to Buy in May
foolmart.com
5 Top Stocks to Buy in May
Sent On

04/05/2018

Gilead Denies It Stumbled: Is The Selling Overdone Or Just Starting?
seekingalpha.com
Gilead Denies It Stumbled: Is The Selling Overdone Or Just Starting?
Sent On

03/05/2018

News Alert: Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene
geekwire.com
News Alert: Longtime Juno Therapeutics CEO Hans Bishop leaves role after acquisition by Celgene
Sent On

24/04/2018

Ready for the Next Wave of the Biotech Bull?
zacks.com
Ready for the Next Wave of the Biotech Bull?
Sent On

07/04/2018

Topics: Bill Maher: The US Media...; Prediction of Outcome from Steel...; Celgene Will Rebound to $100 and many other
whotrades.eu
Topics: Bill Maher: The US Media...; Prediction of Outcome from Steel...; Celgene Will Rebound to $100 and many other
Sent On

04/03/2018

Tesla Poised To Post Massive Q1 Loss
seekingalpha.com
Tesla Poised To Post Massive Q1 Loss
Sent On

02/03/2018

Bitcoin Vs. Amazon Vs. PayPal
seekingalpha.com
Bitcoin Vs. Amazon Vs. PayPal
Sent On

15/02/2018

Ford Looks Past Tesla's Gigafactory To A 'Post-Lithium-Ion' Future
seekingalpha.com
Ford Looks Past Tesla's Gigafactory To A 'Post-Lithium-Ion' Future
Sent On

30/01/2018

GeekWire's Most-Read Stories of the Week
geekwire.com
GeekWire's Most-Read Stories of the Week
Sent On

28/01/2018

How to Position Your Money for Big Profits Before the Next Big M&A Announcement
totalwealthresearch.com
How to Position Your Money for Big Profits Before the Next Big M&A Announcement
Sent On

25/01/2018

GeekWire Mid-Week Update, Presented by Wells Fargo
geekwire.com
GeekWire Mid-Week Update, Presented by Wells Fargo
Sent On

24/01/2018

Oscar nods for Amazon and Netflix | Self-driving Ubers in 18 months? | Why Celgene is buying Juno Therapeutics | How to build an Amazon door desk
geekwire.com
Oscar nods for Amazon and Netflix | Self-driving Ubers in 18 months? | Why Celgene is buying Juno Therapeutics | How to build an Amazon door desk
Sent On

23/01/2018

Amazon Go draws a crowd | $9B Juno acquisition is a dramatic deal for a rising biotech star | Microsoft gives Minecraft a chemistry update
geekwire.com
Amazon Go draws a crowd | $9B Juno acquisition is a dramatic deal for a rising biotech star | Microsoft gives Minecraft a chemistry update
Sent On

22/01/2018

Breaking: Juno Therapeutics to be acquired by Celgene for $9B
geekwire.com
Breaking: Juno Therapeutics to be acquired by Celgene for $9B
Sent On

22/01/2018

ZeroHedge Frontrunning: January 22
zerohedge.com
ZeroHedge Frontrunning: January 22
Sent On

22/01/2018

Juno stock surges 50% amid buyout report | Usermind and LumaTax raise cash | Boeing to sell airplane seats
geekwire.com
Juno stock surges 50% amid buyout report | Usermind and LumaTax raise cash | Boeing to sell airplane seats
Sent On

17/01/2018

My top biotech pick for 2018 is ready to soar 110.5% in 12 months...
strategictechinvestor.com
My top biotech pick for 2018 is ready to soar 110.5% in 12 months...
Sent On

16/01/2018

Today's WorldView: Iran’s protests are fading, but Iranians are still angry
washingtonpost.com
Today's WorldView: Iran’s protests are fading, but Iranians are still angry
Sent On

04/01/2018

Celgene Crashes: A Reassessment
seekingalpha.com
Celgene Crashes: A Reassessment
Sent On

27/10/2017

Prospect Capital's Bomb Drop: Sifting Through The Rubble
seekingalpha.com
Prospect Capital's Bomb Drop: Sifting Through The Rubble
Sent On

30/08/2017

Are You Being Screwed?
angelnexus.com
Are You Being Screwed?
Sent On

18/05/2017

Apple: Why We Expect New All-Time Highs In 2017
seekingalpha.com
Apple: Why We Expect New All-Time Highs In 2017
Sent On

18/01/2017

Energy Focus: Income Opportunities on SLB
investingsignal-mail.com
Energy Focus: Income Opportunities on SLB
Sent On

17/01/2017

Gilead Sciences - Top Biotech Pick For The Next Decade
seekingalpha.com
Gilead Sciences - Top Biotech Pick For The Next Decade
Sent On

10/01/2017

Goldman Sachs (GS) Offering Possible 13.51% Return
tradingforkeeps.com
Goldman Sachs (GS) Offering Possible 13.51% Return
Sent On

25/10/2016

Amazon (AMZN) Offering Possible 70.94% Return
tradingforkeeps.com
Amazon (AMZN) Offering Possible 70.94% Return
Sent On

24/10/2016

Alcoa (AA) Offering Possible 5.71% Return
tradingforkeeps.com
Alcoa (AA) Offering Possible 5.71% Return
Sent On

20/10/2016

September 10 Insights: 7 Defense Stocks to Anchor Your Portfolio's Offense
investorplace.com
September 10 Insights: 7 Defense Stocks to Anchor Your Portfolio's Offense
Sent On

10/09/2016

Celgene (CELG) Offering Possible 29.2% Return
tradingforkeeps.com
Celgene (CELG) Offering Possible 29.2% Return
Sent On

08/09/2016

Express Scripts (ESRX) Offering Possible 11.11% Return
tradingforkeeps.com
Express Scripts (ESRX) Offering Possible 11.11% Return
Sent On

07/09/2016

United Health (UNH) Offering Possible 10.62% Return
tradingforkeeps.com
United Health (UNH) Offering Possible 10.62% Return
Sent On

06/09/2016

Chevron (CVX) Offering Possible 9.17% Return
tradingforkeeps.com
Chevron (CVX) Offering Possible 9.17% Return
Sent On

08/08/2016

Baidu (BIDU) Offering Possible 56.25% Return
tradingforkeeps.com
Baidu (BIDU) Offering Possible 56.25% Return
Sent On

23/06/2016

Total result: 99
Page
of 1
Can't find what you looking for? Tell us!

Copyright © 2019–2024 SimilarMail.